FdaApplication
ANDA 217595
Identifiers
- fda_app_no: ANDA217595
Properties
| Property | Value |
|---|---|
| applicant_name | STERISCIENCE PTE LTD |
| application_type | ANDA |
| approval_date | 2025-09-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZIPRASIDONE MESYLATE | ZIPRASIDONE MESYLATE | EQ 20MG BASE/VIAL | POWDER;INTRAMUSCULAR |
1 product